{"id":2548,"date":"2024-11-20T11:49:38","date_gmt":"2024-11-20T10:49:38","guid":{"rendered":"https:\/\/ppc-montpellier.com\/?p=2548"},"modified":"2025-01-20T11:56:23","modified_gmt":"2025-01-20T10:56:23","slug":"nulisa-a-new-technologie-at-the-lab","status":"publish","type":"post","link":"https:\/\/ppc-montpellier.com\/index.php\/2024\/11\/20\/nulisa-a-new-technologie-at-the-lab\/","title":{"rendered":"NULISA: a new technologie at the lab"},"content":{"rendered":"\n<p>Big news of the month; the arrival of the Alamar ARGO HT NULISA\u2122 system, a major technological advance for the detection of previously inaccessible biomarkers. <\/p>\n\n\n\n<p>This technology enables the simultaneous analysis of up to 250 proteins, including critical biomarkers such as pTau217 and \u03b1-Synuclein, NULISA\u2122 opens up new perspectives for research in: Neurology \/ Inflammation \/ Oncology \/ Immunology ..and many others!<\/p>\n\n\n\n<p>Using just 25 to 35 \u00b5L of sample, this platform makes it possible to work on complex matrices (serum, plasma, CSF, cell culture supernatant, etc.) while guaranteeing ultra-sensitive analysis.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"768\" src=\"https:\/\/ppc-montpellier.com\/wp-content\/uploads\/2025\/01\/NULISA-2-1024x768.jpg\" alt=\"\" class=\"wp-image-2550\" style=\"width:703px;height:auto\" srcset=\"https:\/\/ppc-montpellier.com\/wp-content\/uploads\/2025\/01\/NULISA-2-980x735.jpg 980w, https:\/\/ppc-montpellier.com\/wp-content\/uploads\/2025\/01\/NULISA-2-480x360.jpg 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) 1024px, 100vw\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Big news of the month; the arrival of the Alamar ARGO HT NULISA\u2122 system, a major technological advance for the detection of previously inaccessible biomarkers. This technology enables the simultaneous analysis of up to 250 proteins, including critical biomarkers such as pTau217 and \u03b1-Synuclein, NULISA\u2122 opens up new perspectives for research in: Neurology \/ Inflammation [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":2549,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"off","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[22],"tags":[],"class_list":["post-2548","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ppc-en"],"_links":{"self":[{"href":"https:\/\/ppc-montpellier.com\/index.php\/wp-json\/wp\/v2\/posts\/2548","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ppc-montpellier.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppc-montpellier.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppc-montpellier.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ppc-montpellier.com\/index.php\/wp-json\/wp\/v2\/comments?post=2548"}],"version-history":[{"count":1,"href":"https:\/\/ppc-montpellier.com\/index.php\/wp-json\/wp\/v2\/posts\/2548\/revisions"}],"predecessor-version":[{"id":2551,"href":"https:\/\/ppc-montpellier.com\/index.php\/wp-json\/wp\/v2\/posts\/2548\/revisions\/2551"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppc-montpellier.com\/index.php\/wp-json\/wp\/v2\/media\/2549"}],"wp:attachment":[{"href":"https:\/\/ppc-montpellier.com\/index.php\/wp-json\/wp\/v2\/media?parent=2548"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppc-montpellier.com\/index.php\/wp-json\/wp\/v2\/categories?post=2548"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppc-montpellier.com\/index.php\/wp-json\/wp\/v2\/tags?post=2548"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}